Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps

Inclusion Criteria: * Adult patients (≥ 18 years) * Presenting with primary immunodeficiency * Having received subcutaneous injections of immunoglobulin at home using an automatic pump for at least 1 month at the time of inclusion * For whom the investigator decides to maintain immunoglobulin replacement therapy with subcutaneous injections of Gammanorm® 165 mg/mL at home * Having signed an informed consent form Exclusion Criteria: * Patient currently participating in another interventional study at the time of inclusion